Clarivate Shares Drop Nearly 7% as Q3 Revenue Miss Overshadows Earnings Beat
Clarivate (CLVT) reported Q3 adjusted EPS of $0.21, beating estimates, but revenue fell 9.2% YoY to $481.6M, missing expectations. The company guided Q4 revenue below consensus and announced the completion of a divestiture. Shares dropped 6.63% premarket.
How this was made
The 30-second read
Why it matters
Despite an adjusted EPS beat, the revenue decline and below-consensus revenue guidance appear to dominate the market reaction, while improving organic ACV and segment ACV trends offer a partial offset.
Market read
This is a same-day earnings-and-guidance repricing for CLVT, with the revenue miss and sales outlook likely outweighing the EPS beat.
What to watch
The article highlights the Life Sciences & Healthcare divestiture completed Oct. 6, which can distort year-over-year and guidance comparability; traders may separate continuing-ops recurring metrics from headline revenue.
Background
Clarivate is reshaping its portfolio, including completing a Life Sciences & Healthcare segment sale on Oct. 6, 2026.
Ticker impact
Clarivate beat EPS but reported continuing-ops revenue down 9.2% to $481.6M, missing $566.77M, and guided Q4 revenue below consensus.
Shares likely face continued downside pressure as investors reprice the revenue trajectory and portfolio-disposal impact on reported sales.
The article attributes the premarket drop to the revenue shortfall versus consensus and notes Q4 and full-year revenue guidance remain below analyst expectations, even as organic ACV improves.
Market effects
Signals continued investor sensitivity to revenue quality and reported-sales effects from portfolio reshaping in information and analytics software/services.
Primarily US-listed large-cap software/services sentiment via a single-name earnings-and-guidance repricing.
Limited beyond the company, but may influence how investors discount reported revenue during divestiture-driven portfolio transitions.
Counterpoint
Organic revenue (+0.4%) and organic annual contract value (+1.8%) improved, suggesting the revenue miss may be more accounting/portfolio-driven than demand deterioration.
Key entities
- companyClarivate Plc
Global information, analytics, and technology solutions provider reporting Q3 results and issuing Q4 and full-year guidance.
- personMatti Shem Tov
CEO quoted highlighting improvements in organic recurring revenue and positive ACV growth in the Intellectual Property segment.
